Quality of care for secondary cardiovascular disease prevention in 2009–2017: population-wide cohort study of antiplatelet therapy use in Scotland

Quality of care for secondary cardiovascular disease prevention in 2009–2017: population-wide cohort study of antiplatelet therapy use in Scotland

<p><strong>Background:</strong> Antiplatelet therapy (APT) can substantially reduce the risk of further vascular events in individuals with established atherosclerotic cardiovascular disease (ASCVD). However, knowledge regarding the extent and determinants of APT use is li...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Thalmann, I, Preiss, D, Schlackow, I, Gray, A, Mihaylova, B
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	BMJ Publishing Group 2023

Eitemau Tebyg

Antiplatelet therapy use for the secondary prevention of cardiovascular disease in 2009-2017: a population-wide retrospective cohort study of Scotland
gan: Thalmann, I, et al.
Cyhoeddwyd: (2022)

Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009–2017
gan: Thalmann, I, et al.
Cyhoeddwyd: (2022)

Cholesterol- and blood pressure-lowering drug use for secondary cardiovascular prevention in 2004 - 2013 Europe
gan: Achelrod, D, et al.
Cyhoeddwyd: (2016)

Determinants of medication use for the secondary prevention of cardiovascular disease
gan: Thalmann, I
Cyhoeddwyd: (2021)

Antiplatelets in secondary stroke prevention
gan: Olga eShulga, et al.
Cyhoeddwyd: (2011-07-01)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
gan: Hennekens, C, et al.
Cyhoeddwyd: (1989)

Antiplatelet therapy in secondary prevention of ischemic stroke
gan: V. A. Parfyonov, et al.
Cyhoeddwyd: (2015-12-01)

Antiplatelet treatment in primary and secondary stroke prevention in women.
gan: Caso, V, et al.
Cyhoeddwyd: (2012)

Antiplatelet treatment in primary and secondary stroke prevention in women
gan: Caso, V, et al.
Cyhoeddwyd: (2012)

Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
gan: Srivastava Padma
Cyhoeddwyd: (2010-01-01)

Antiplatelet therapy as an element of primary and secondary prevention of ischemic stroke
gan: E. Y. Solovyova, et al.
Cyhoeddwyd: (2016-12-01)

PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE AND ANTIPLATELET THERAPY. CLINICAL LECTURE
gan: L. O. Minushkina
Cyhoeddwyd: (2017-12-01)

THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS AFTER CORONARY STENTING IN PATIENTS WITH UNSTABLE ANGINA AND RESISTANCE TO ANTIPLATELET AGENTS
gan: E. A. Medvedeva, et al.
Cyhoeddwyd: (2017-12-01)

ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
gan: E. Y. Kitaeva, et al.
Cyhoeddwyd: (2017-04-01)

Secondary prevention with antiplatelet medications in patients with antiphospholipid antibody-related stroke
gan: Wookjin Yang, et al.
Cyhoeddwyd: (2025-03-01)

Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom
gan: Xuejun Liu, et al.
Cyhoeddwyd: (2023-10-01)

Antiplatelet treatment patterns and outcomes of secondary stroke prevention in the United States
gan: Ellen O'Brien, et al.
Cyhoeddwyd: (2023-02-01)

Antiplatelets or anticoagulants? Secondary prevention in cervical artery dissection: an updated meta-analysis
gan: Ei Zune The, et al.
Cyhoeddwyd: (2022-06-01)

TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE
gan: Muhammad Tariq, et al.
Cyhoeddwyd: (2018-12-01)

Diabetes Mellitus and Cardiovascular Prevention: The Role and the Limitations of Currently Available Antiplatelet Drugs
gan: A. Tufano, et al.
Cyhoeddwyd: (2011-01-01)

Novel antiplatelet agents in the prevention of cardiovascular complications &ndash; focus on ticagrelor
gan: Margaret M Marczewski, et al.
Cyhoeddwyd: (2010-05-01)

ANTIPLATELET THERAPY IN THE PREVENTION OF CEREBROVASCULAR ACCIDENTS
gan: O. V. Rodionova, et al.
Cyhoeddwyd: (2017-03-01)

Antiplatelet agents in stroke prevention.
gan: Peto, R
Cyhoeddwyd: (1988)

Secondary care for people experiencing homelessness in Scotland: a retrospective cohort study
gan: Haris Haseeb, et al.
Cyhoeddwyd: (2025-03-01)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
gan: N. В. Perepech, et al.
Cyhoeddwyd: (2018-05-01)

Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland
gan: Labuz-Roszak Beata, et al.
Cyhoeddwyd: (2012-10-01)

Use of Antiplatelets for Primary and Secondary Prevention of Cardiovascular Events in the Medical Outpatient Setting of a Tertiary Centre in Nigeria: A Six-Month Review
gan: Uzoma Chukwunonso Okechukwu, et al.
Cyhoeddwyd: (2024-06-01)

Antiplatelet agents for the treatment and prevention of atherothrombosis.
gan: Patrono, C, et al.
Cyhoeddwyd: (2011)

A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility.
gan: Nikola Sprigg, et al.
Cyhoeddwyd: (2008-08-01)

THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY
gan: D. A. Andreev
Cyhoeddwyd: (2015-09-01)

THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY
gan: D. A. Andreev
Cyhoeddwyd: (2015-09-01)

CARDIOVASCULAR PREVENTION 2017. NATIONAL GUIDELINES
gan: article Editorial
Cyhoeddwyd: (2018-07-01)

Antiplatelet agents for the treatment and prevention of coronary atherothrombosis
gan: Patrono, C, et al.
Cyhoeddwyd: (2017)

Precision antiplatelet therapy for the prevention of ischaemic stroke
gan: David Wang

ANTIPLATELET THERAPY IN PROPHILAXY OF NEGATIVE CARDIOVASCULAR EVENTS AFTER CORONARY REVASCULARIZATION. IS THERE A CONSENSUS?
gan: Yu. I. Grinschtein, et al.
Cyhoeddwyd: (2014-06-01)

The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review.
gan: Morton, R, et al.
Cyhoeddwyd: (2015)

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
gan: Schlackow, I, et al.
Cyhoeddwyd: (2017)

Dual Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke: A Ghost from the Past or a New Frontier?
gan: Clotilde Balucani, et al.
Cyhoeddwyd: (2010-01-01)

Abstract 136: Antiplatelet Regimens for Secondary Prevention in Minor Ischemic Stroke or TIA: A Network Meta‐Analysis
gan: Hesham Kelani
Cyhoeddwyd: (2023-11-01)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
gan: Martin Vališ, et al.
Cyhoeddwyd: (2021-02-01)